1. Home
  2. ENLV vs RVP Comparison

ENLV vs RVP Comparison

Compare ENLV & RVP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ENLV
  • RVP
  • Stock Information
  • Founded
  • ENLV 2005
  • RVP 1994
  • Country
  • ENLV Israel
  • RVP United States
  • Employees
  • ENLV N/A
  • RVP N/A
  • Industry
  • ENLV Biotechnology: Pharmaceutical Preparations
  • RVP Medical/Dental Instruments
  • Sector
  • ENLV Health Care
  • RVP Health Care
  • Exchange
  • ENLV Nasdaq
  • RVP Nasdaq
  • Market Cap
  • ENLV 20.7M
  • RVP 20.5M
  • IPO Year
  • ENLV 1995
  • RVP 2001
  • Fundamental
  • Price
  • ENLV $0.92
  • RVP $0.74
  • Analyst Decision
  • ENLV Strong Buy
  • RVP
  • Analyst Count
  • ENLV 2
  • RVP 0
  • Target Price
  • ENLV $10.00
  • RVP N/A
  • AVG Volume (30 Days)
  • ENLV 62.6K
  • RVP 39.4K
  • Earning Date
  • ENLV 06-13-2025
  • RVP 05-14-2025
  • Dividend Yield
  • ENLV N/A
  • RVP N/A
  • EPS Growth
  • ENLV N/A
  • RVP N/A
  • EPS
  • ENLV N/A
  • RVP N/A
  • Revenue
  • ENLV N/A
  • RVP $33,049,532.00
  • Revenue This Year
  • ENLV N/A
  • RVP N/A
  • Revenue Next Year
  • ENLV N/A
  • RVP N/A
  • P/E Ratio
  • ENLV N/A
  • RVP N/A
  • Revenue Growth
  • ENLV N/A
  • RVP N/A
  • 52 Week Low
  • ENLV $0.81
  • RVP $0.56
  • 52 Week High
  • ENLV $1.84
  • RVP $1.22
  • Technical
  • Relative Strength Index (RSI)
  • ENLV 44.97
  • RVP 54.76
  • Support Level
  • ENLV $0.86
  • RVP $0.67
  • Resistance Level
  • ENLV $0.91
  • RVP $0.76
  • Average True Range (ATR)
  • ENLV 0.06
  • RVP 0.05
  • MACD
  • ENLV 0.00
  • RVP 0.01
  • Stochastic Oscillator
  • ENLV 47.06
  • RVP 79.45

About ENLV Enlivex Therapeutics Ltd.

Enlivex Therapeutics Ltd is an Israel-based development-stage biopharmaceutical company. It is focused on developing and commercializing an allogeneic drug pipeline for rebalancing immune hyper-responses. The company's Allocetra is an immunotherapy that is being developed to rebalance a life-threatening unbalanced immune system, using the immune system's own natural regulation mechanisms.

About RVP Retractable Technologies Inc.

Retractable Technologies Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession. The company's products are the VanishPoint 0.5mL insulin syringe; 1mL tuberculin, insulin, and allergy antigen syringes; 0.5mL, 1mL, 2mL, 3mL, 5mL, and 10mL syringes; the small diameter tube adapter; the blood collection tube holder; the allergy tray; the IV safety catheter; the Patient Safe syringes; the Patient Safe Luer Cap; the VanishPoint Blood Collection Set; and the EasyPoint needle, as well as a standard 3mL syringe packaged with an EasyPoint needle. The company also sells VanishPoint autodisable syringes in the international market in addition to the Company's other products.

Share on Social Networks: